Literature DB >> 20832925

Acute caffeine consumption enhances the executive control of visual attention in habitual consumers.

Tad T Brunyé1, Caroline R Mahoney, Harris R Lieberman, Grace E Giles, Holly A Taylor.   

Abstract

Recent work suggests that a dose of 200-400 mg caffeine can enhance both vigilance and the executive control of visual attention in individuals with low caffeine consumption profiles. The present study seeks to determine whether individuals with relatively high caffeine consumption profiles would show similar advantages. To this end, we examined the effects of four caffeine doses (0 mg, 100 mg, 200 mg, 400 mg) on low- and high-level visual attention in individuals with high consumption profiles (n=36), in a double-blind study using a repeated measures design. Results from the Attention Network Test indicated that caffeine enhanced both vigilance and the executive control of visual attention, but only at the highest administered dose (400 mg). We demonstrate that in habitual consumers high doses of caffeine can produce beneficial changes in visual attention. These results carry implications for the theorized interactions between caffeine, adenosine and dopamine in brain regions mediating visual attention. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20832925     DOI: 10.1016/j.bandc.2010.07.006

Source DB:  PubMed          Journal:  Brain Cogn        ISSN: 0278-2626            Impact factor:   2.310


  19 in total

1.  The effects of caffeine on option generation and subsequent choice.

Authors:  Jan Alexander Häusser; Alexander Schlemmer; Stefan Kaiser; Annemarie Kalis; Andreas Mojzisch
Journal:  Psychopharmacology (Berl)       Date:  2014-02-28       Impact factor: 4.530

2.  Single and combined effects of selected pharmaceuticals at sublethal concentrations on multiple biomarkers in Carassius auratus.

Authors:  Zhihua Li; Guanghua Lu; Xiaofan Yang; Chao Wang
Journal:  Ecotoxicology       Date:  2011-09-24       Impact factor: 2.823

3.  Energy drinks and their component modulate attention, memory, and antioxidant defences in rats.

Authors:  M T Costa Valle; N S Couto-Pereira; C Lampert; D M Arcego; A P Toniazzo; R P Limberger; E Dallegrave; C Dalmaz; M D Arbo; M B Leal
Journal:  Eur J Nutr       Date:  2017-08-12       Impact factor: 5.614

4.  Psychopharmacology of theobromine in healthy volunteers.

Authors:  Matthew J Baggott; Emma Childs; Amy B Hart; Eveline de Bruin; Abraham A Palmer; Joy E Wilkinson; Harriet de Wit
Journal:  Psychopharmacology (Berl)       Date:  2013-02-19       Impact factor: 4.530

Review 5.  Caffeine as an attention enhancer: reviewing existing assumptions.

Authors:  Suzanne J L Einöther; Timo Giesbrecht
Journal:  Psychopharmacology (Berl)       Date:  2012-12-16       Impact factor: 4.530

6.  Caffeine increases the motivation to obtain non-drug reinforcers in rats.

Authors:  A Brianna Sheppard; Skyler C Gross; Sarah A Pavelka; Melanie J Hall; Matthew I Palmatier
Journal:  Drug Alcohol Depend       Date:  2012-02-13       Impact factor: 4.492

7.  EEG Microstates in Early Phase Psychosis: The Effects of Acute Caffeine Consumption.

Authors:  Jenna N Bissonnette; T-Jay Anderson; Katelyn J McKearney; Philip G Tibbo; Derek J Fisher
Journal:  Clin EEG Neurosci       Date:  2022-03-08       Impact factor: 2.046

8.  Effects of concurrent caffeine and mobile phone exposure on local target probability processing in the human brain.

Authors:  Attila Trunk; Gábor Stefanics; Norbert Zentai; Ivett Bacskay; Attila Felinger; György Thuróczy; István Hernádi
Journal:  Sci Rep       Date:  2015-09-23       Impact factor: 4.379

9.  Drinking coffee enhances neurocognitive function by reorganizing brain functional connectivity.

Authors:  Hayom Kim; Sung Hoon Kang; Soon Ho Kim; Seong Hwan Kim; Jihyeon Hwang; Jae-Gyum Kim; Kyungreem Han; Jung Bin Kim
Journal:  Sci Rep       Date:  2021-07-13       Impact factor: 4.379

10.  Caffeine promotes global spatial processing in habitual and non-habitual caffeine consumers.

Authors:  Grace E Giles; Caroline R Mahoney; Tad T Brunyé; Holly A Taylor; Robin B Kanarek
Journal:  Front Hum Neurosci       Date:  2013-10-17       Impact factor: 3.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.